Comparative outcomes of laparoscopic fundoplication and magnetic sphincter augmentation: is there a difference?

Abstract

The prevalence of gastrointestinal reflux disease and reflux-related complications continue to rise, and treatment options are limited. Medical management alone is often ineffective and chronic use carries inherent risk. Magnetic sphincter augmentation represents a reasonable and viable treatment option for appropriately selected patients. Compared to surgical wraps, magnetic sphincter augmentation (MSA) may provide similar rates of patient satisfaction, anti-acid medication cessation, and decreased esophageal acid exposure. Additionally, MSA may lower postoperative gas bloat symptoms and better preserve the ability to belch or vomit, versus surgical wraps. Magnetic sphincter augmentation, however, is still relatively new, and further study is needed to evaluate and compare outcomes more appropriately to that of surgical wraps.

Keywords

LINX® / magnetic sphincter augmentation / fundoplication / anti-reflux surgery / gastroesophageal reflux disease (GERD) / reflux / minimally invasive surgery / foregut surgery

References

[1] El-Serag HB,Winchester CC.Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.Gut2014;63:871-80 PMCID:PMC4046948

[2] Aiolfi A,Bernardi D.Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis.Int J Surg2018;52:82-8

[3] Yamasaki T,Eisa M,Fass R.The changing epidemiology of gastroesophageal reflux disease: are patients getting younger?.J Neurogastroenterol Motil2018;24:559-69 PMCID:PMC6175565

[4] Bonavina L,Schoppmann SF.Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication.Surg Endosc2021;35:3449-58 PMCID:PMC8195805

[5] Asti E,Lazzari V.“Magnetic sphincter augmentation for gastroesophageal refluc disease: review of clinical studies”.Updates Surg2018;70:323-30

[6] Fass R.Therapeutic options for refractory gastroesophageal reflux disease.J Gastroenterol Hepatol2012;27 Suppl 3:3-7

[7] Robinson B,Cassera MA,Sharata A.20 years later: laparoscopic fundoplication durability.Surg Endosc2015;29:2520-4

[8] Reynolds JL,Nieh A.Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD.Surg Endosc2016;30:3225-30

[9] Asti E,Lovece A,Bonavina L.Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis.Medicine (Baltimore)2016;95:e4366 PMCID:PMC5265862

[10] Broderick RC,Cheverie JN.Magnetic sphincter augmentation: a viable rescue therapy for symptomatic reflux following bariatric surgery.Surg Endosc2020;34:3211-5

[11] Buckley FP 3rd,Freeman K,Heidrick R.Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation.Surg Endosc2018;32:1762-8 PMCID:PMC5845067

[12] U.S. FOOD & DRUG. Premarket Approval (PMA). Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100049 [Last accessed on 20 Jul 2022]

[13] Richards WO.Comparative analysis of laparoscopic fundoplication and magnetic sphincter augmentation for the treatment of medically refractory GERD.Am Surg2018;84:1762-7

[14] Reynolds JL,Wu P,Bildzukewicz N.Laparoscopic magnetic sphincter augmentation vs laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients.J Am Coll Surg2015;221:123-8

[15] Telem DA,Shah PC.SAGES technology and value assessment committee (TAVAC) safety and effectiveness analysis: LINX^® reflux management system.Surg Endosc2017;31:3811-26

[16] Schizas D,Papoutsi E.LINX^® reflux management system to bridge the “treatment gap” in gastroesophageal reflux disease: a systematic review of 35 studies.World J Clin Cases2020;8:294-305 PMCID:PMC7000944

[17] Bell R,Louie B.Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.Gastrointest Endosc2019;89:14-22.e1

[18] Ganz RA,Taiganides PA.Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux.Clin Gastroenterol Hepatol2016;14:671-7

[19] Guidozzi N,Ahmed AR,Markar SR.Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis.Dis Esophagus2019;32:doz031

[20] Louie BE,Shultz D,Vallières E.Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease.Ann Thorac Surg2014;98:498-504; discussion 504

[21] Sheu EG,Nath B,Rattner DW.A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication.Surg Endosc2015;29:505-9

[22] Riegler M,Bonavina L,Horbach T.Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study.Surg Endosc2015;29:1123-9

[23] Warren HF,Lipham JC.Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.Surg Endosc2016;30:3289-96

[24] O'Neill SM,Colvin JS,Perry KA.S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study.Surg Endosc2022;

[25] Wu H,Wong HJ.Impedance planimetry (EndoFLIP™) after magnetic sphincter augmentation (LINX®) compared to fundoplication.Surg Endosc2022;

[26] Chen MY,Wu A.Efficacy of magnetic sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease in short term: a meta-analysis.Can J Gastroenterol Hepatol2017;2017:9596342 PMCID:PMC5390656

[27] Zhuang QJ,Chen SF,Xiao YL.Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: a systematic review and meta-analysis.J Dig Dis2021;22:695-705

[28] Sterbling HM.Laparoscopic anti-reflux operation: fundoplication vs. Linx - techniques and outcomes.Shanghai Chest2021;5:9-9

[29] Skubleny D,Dang J.LINX^® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis.Surg Endosc2017;31:3078-84

[30] Tatum JM,Bildzukewicz N,Houghton CC.Minimal versus obligatory dissection of the diaphragmatic hiatus during magnetic sphincter augmentation surgery.Surg Endosc2019;33:782-8

[31] Sterris JA,Bildzukewicz NA.Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons.Curr Opin Gastroenterol2020;36:323-8